scispace - formally typeset
M

Mariam Semmo

Researcher at University of Bern

Publications -  9
Citations -  177

Mariam Semmo is an academic researcher from University of Bern. The author has contributed to research in topics: Type 2 diabetes & Tolvaptan. The author has an hindex of 6, co-authored 9 publications receiving 118 citations.

Papers
More filters
Journal ArticleDOI

Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis

TL;DR: In this paper, the authors compared the efficacy of fully automated closed-loop insulin delivery vs. usual care in patients undergoing hemodialysis while in hospital and found that those patients receiving closed loop insulin delivery significantly increased the proportion of time when a continuous glucose monitor was in the target range of 5.6-10.0 mmol/l by 37.6 percent without increasing the risk of hypoglycemia.
Journal ArticleDOI

Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)

TL;DR: This review provides an update on the therapeutic implication of newly developed AVP receptor antagonists in respective disorders, such as chronic heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion.
Journal ArticleDOI

T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.

TL;DR: ‘Anti‐HBc alone’ individuals showed HBV‐specific T‐cell and memory B‐cell responses typical of previous viral exposure and protective memory, suggesting a resolved infection.
Journal ArticleDOI

Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan

TL;DR: The results indicate that tolvaptan does not significantly affect HRQoL in patients with ADPKD who tolerate treatment beyond the first 3 months of therapy, except for patient satisfaction, which was increased.